SCHEMBL15519063

SCHEMBL15519063

Nc1ncnc2c1c(I)nn2C[C@@H]1CCCN1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 4/20 0.58
KDR P35968 4/20 0.58
EGFR P00533 4/20 0.58
ABL1 P00519 4/20 0.58
PIK3CD O00329 4/20 0.58
HCK P08631 3/20 0.58
PIK3CA P42336 3/20 0.58
PIK3CB P42338 3/20 0.58
MTOR P42345 3/20 0.58
PIK3CG P48736 3/20 0.58
EPHB4 P54760 3/20 0.58
PRKDC P78527 3/20 0.58
PI4KB Q9UBF8 3/20 0.58
JAK2 O60674 3/20 0.48
DYRK3 O43781 2/20 0.48
CDK1 P06493 2/20 0.48
ROS1 P08922 2/20 0.48
RPS6KB1 P23443 2/20 0.48
CDK2 P24941 2/20 0.48
CSNK1A1 P48729 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15519064 1.00 SRC (0.58) SRCKDREGFRABL1PIK3CD
SCHEMBL13860324 1.00 SRC (0.58) SRCKDREGFRABL1PIK3CD
SCHEMBL25678106 0.81 JAK2 (0.53) SRCKDREGFRABL1PIK3CD
SCHEMBL3684615 0.80 JAK2 (0.56) SRCKDREGFRABL1PIK3CD
SCHEMBL14617265 0.80 ABL1 (0.64) SRCKDREGFRABL1PIK3CD
SCHEMBL25678092 0.80 SRC (0.52) SRCKDREGFRABL1PIK3CD
SCHEMBL26061889 0.78 SRC (0.58) SRCKDREGFRABL1PIK3CD
SCHEMBL28467319 0.76 JAK2 (0.56) SRCKDREGFRABL1PIK3CD
SCHEMBL13860354 0.75 EGFR (0.65) SRCKDREGFRABL1PIK3CD
SCHEMBL13860356 0.75 EGFR (0.65) SRCKDREGFRABL1PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2892900-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORS Principia Biopharma Inc. (US) 2015-07-15 EP disclosed
WO-2014039899-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORS PRINCIPIA BIOPHARMA INC. (US) 2014-03-13 WO disclosed